诺华在圣地亚哥新研发中心奠基

2026-02-07 04:31

Novartis (NVS) on Friday said it has broken ground on a 466,000-square-foot biomedical research center in San Diego.
The facility is expected to begin operations in 2029 and house 1,000 workers.
The Swiss pharma said the site would utilize artificial intelligence, data, and computational capabilities.
Novartis noted that the center is part of a $23B investment in the US, which includes a new manufacturing facility in North Carolina and a radioligand therapy (RLT) manufacturing facility in Carlsbad, Calif. The company is also planning new RLT manufacturing locations in Florida and Texas.

More on Novartis